JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simpson, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simpson, L. L.

Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins

LL Simpson

Ammonium chloride (1-8 mM) and methylamine hydrochloride (1-16 mM) produce concentration-dependent antagonism of the onset of neuromuscular blockade caused by botulinum toxin types A, B and C (all at 1 X 10(-11) M) and by tetanus toxin (3 X 10(-10) M). Neither drug antagonizes the onset of paralysis caused by beta-bungarotoxin (1 X 10(- 7) M) or by taipoxin (1 X 10(-8) M). At concentrations that produce antagonism of clostridial neurotoxins, ammonium chloride and methylamine hydrochloride (8-10 mM) do not inactivate toxin molecules, nor do they produce irreversible changes in tissue function. When studied under conditions that impose partial synchrony on the mechanism of clostridial neurotoxin action, ammonium chloride and methylamine hydrochloride do not inhibit ligand binding and do not reverse neuromuscular blockade. The drugs act solely to antagonize internalization of toxins by cholinergic nerve endings. As a result of inhibiting the process of internalization, the drugs trap the toxins at an antitoxin sensitive site.

Volume 225, Issue 3, pp. 546-552, 06/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Fischer and M. Montal
Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes
PNAS, June 19, 2007; 104(25): 10447 - 10452.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Kalandakanond and J. A. Coffield
Cleavage of SNAP-25 by Botulinum Toxin Type A Requires Receptor-Mediated Endocytosis, pH-Dependent Translocation, and Zinc
J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 980 - 986.
[Abstract] [Full Text]

Home page
 Physiol. Rev.Home page
G. Schiavo, M. Matteoli, and C. Montecucco
Neurotoxins Affecting Neuroexocytosis
Physiol Rev, April 1, 2000; 80(2): 717 - 766.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. A. Coffield, N. M. Bakry, A. B. Maksymowych, and L. L. Simpson
Characterization of a Vertebrate Neuromuscular Junction That Demonstrates Selective Resistance to Botulinum Toxin
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1509 - 1516.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
A. B. Maksymowych and L. L. Simpson
Binding and Transcytosis of Botulinum Neurotoxin by Polarized Human Colon Carcinoma Cells
J. Biol. Chem., August 21, 1998; 273(34): 21950 - 21957.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Matteoli, C. Verderio, O. Rossetto, N. Iezzi, S. Coco, G. Schiavo, and C. Montecucco
Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons
PNAS, November 12, 1996; 93(23): 13310 - 13315.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics.